Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
CDIO Cardio Diagnostics Holdings
1.060+0.050+4.95%
Trading Session
01/31 12:14 ET
High
1.084
Open
1.070
Turnover
3.41K
Low
1.060
Pre Close
1.010
Volume
3.15K
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Head-To-Head Review: Cardio Diagnostics (NASDAQ:CDIO) Versus Celldex Therapeutics (NASDAQ:CLDX)
Cardio Diagnostics (NASDAQ:CDIO – Get Rating) and Celldex Therapeutics (NASDAQ:CLDX – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two companies
Financial Contrast: Cardio Diagnostics (NASDAQ:CDIO) & Quotient (NASDAQ:QTNT)
Cardio Diagnostics (NASDAQ:CDIO – Get Rating) and Quotient (NASDAQ:QTNT – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two companies based
Comparing OncoCyte (NASDAQ:OCX) and Cardio Diagnostics (NASDAQ:CDIO)
OncoCyte (NASDAQ:OCX – Get Rating) and Cardio Diagnostics (NASDAQ:CDIO – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based
Head-To-Head Analysis: Cardio Diagnostics (NASDAQ:CDIO) and Quotient (NASDAQ:QTNT)
Quotient (NASDAQ:QTNT – Get Rating) and Cardio Diagnostics (NASDAQ:CDIO – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based
Cardio Diagnostics (NASDAQ:CDIO) Vs. Quotient (NASDAQ:QTNT) Critical Survey
Cardio Diagnostics (NASDAQ:CDIO – Get Rating) and Quotient (NASDAQ:QTNT – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersCalyxt (NASDAQ:CLXT) stock increased by 140.3% to $0.45 during Tuesday's pre-market session. The company's market cap stands at $21.7 million. Celyad Oncology (NASDAQ:CYAD) shares increased by
12 Health Care Stocks Moving In Monday's After-Market Session
GainersNymox Pharmaceutical (NASDAQ:NYMX) stock moved upwards by 20.7% to $0.52 during Monday's after-market session. The market value of their outstanding shares is at $47.2 million. First Wave BioPh
Critical Analysis: Heska (NASDAQ:HSKA) & Cardio Diagnostics (NASDAQ:CDIO)
Cardio Diagnostics (NASDAQ:CDIO – Get Rating) and Heska (NASDAQ:HSKA – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based o
Healing Sanctuary Clinic Partners With Cardio Diagnostics Holdings Inc to Offer the Epi+Gen CHD Test in Their Medical Practice in Idaho
Leading Medical Practice in Idaho Will be the First Functional Medicine Clinic to Offer the Epi+Gen CHD Precision Cardiovascular Test Cardio Diagnostics Holdings Inc (NASDAQ:CDIO), a leading precision cardiovascular
Cardio Diagnostics Holdings Inc to Attend 41st Annual JP Morgan Healthcare Conference
Cardio Diagnostics Holdings Inc (NASDAQ:CDIO), a precision cardiovascular diagnostics company, announced today that it will attend the JP Morgan Healthcare Conference, January 9-12, 2023. The JP Morgan Healthcare
Company Overview
More
Cardio Diagnostics Holdings, Inc. engages in the provision of medical diagnostic testing services. It also develops and commercialize a series of products for major types of cardiovascular disease and associated co-morbidities including coronary heart disease (CHD), stroke, heart failure, and diabetes. The company is headquartered in Chicago, IL.
CEO： Dr. Meeshanthini Dogan, PhD
Market： NASDAQ
Listing Date： 11/23/2021
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet